WHO ICTRP trial
Assessment of aspirin response in patients with Type 1 diabetes mellitus: a…
EUCTR2011-003122-27-IT · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2011-003122-27-IT |
|---|---|
| Public title | Assessment of aspirin response in patients with Type 1 diabetes mellitus: a pilot study |
| Scientific title | Assessment of aspirin response in patients with Type 1 diabetes mellitus: a pilot study |
| Primary sponsor | POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | type 1 diabetes MedDRA version: 14.1 Level: LLT Classification code 10045228 Term: Type I diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Hormonal diseases [C19] |
| Interventions | Trade Name: CARDIOASPIRIN*30CPR GAST 100MG Pharmaceutical Form: Gastro-resistant tablet Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 100- |
| Registration date | Mar 13, 2012 |
| Secondary IDs | 767/11 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: